The price tag was a mere 10% premium to Livongo's closing price on the previous day. The Motley Fool - 1 … Why Is Everyone Talking About Livongo Health Stock? Even with red ink on the bottom line, I believe Livongo Health is an attractive stock to buy due to its market opportunity. The healthcare-technology provider conducted its initial public offering (IPO) in July … This is good since Teladoc's CEO, Jason Gorevic, will lead the company. Livongo Health shares were trading up 4.21% at $69.32 at time of publication on Wednesday. Livongo Health's (LVGO) third-quarter results are likely to reflect growth in core Livongo for Diabetes solution. "Since we created the Cramer Covid-19 index six months ago, the stay-at-home, work-at-home stocks just have not been able to quit," the "Mad Money" host said. But these three stocks could be bigger winners over the long run. Let's conquer your financial goals together...faster. An analyst's downgrade for one of these stocks caused the other to fall, too. The combination is resonating with patients. @themotleyfool #stocks $TDOC $LVGO $NFLX $AMWL, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Shares of Livongo Health (NASDAQ: LVGO) were tumbling 5.2% lower as of 11:25 a.m. EDT on Monday while shares of Teladoc Health (NYSE: TDOC) were down 6.3%. This seems like an achievable goal as both companies have been exceeding those growth rates for years. "Nearly five months later, the work-from-home tech stocks have given you extraordinary gains, while the traditional slowdown stocks they laid an egg," the "Mad Money" host said. For those seeking ways to bet against current valuations, or simply hedge against the possi... Teladoc will merge with Livongo, and while that may create some intermediate-term bumpiness, I still like Teladoc stock for the long term. Do the numbers hold clues to what lies ahead for the s... MOUNTAIN VIEW, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live bette... Livongo's news of a mega merger with Teladoc made waves late this summer. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). Livongo Health, Inc. Common Stock (LVGO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The stock has a 52-week high of $71.12 and a 52-week low of $15.12. Livongo Health (LVGO) is traded on NASDAQ Exchange in USA. It is located in 150 West Evelyn Avenue and employs 785 people. Some investors initially saw the Teladoc transaction as a bad move. Power 2020 telehealth satisfaction study. Top institutional shareholders include BlackRock Inc. (3.90%), Morgan Stanley (3.00%), Massachusetts Financial … The post 7 Telehealth Stocks Paving the Digital Me... WALTHAM, Mass. The highly defensive healthcare sector was a popular place for successful money managers to put their money to work in the second quarter. These are the healthcare stocks with the best value, fastest growth, and most momentum for October 2020. Remote and virtual medicine has taken off during the pandemic, and these telehealth stocks -- and their investors -- are reaping the rewards. Under the terms of the merger, Livongo shareholders will receive 0.5920x shares of Teladoc Health plus cash of $11.33 for each Livongo share (including the special dividend declared by Livongo… The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. These are the stocks with the best value, fastest growth, and most momentum for October 2020. This month's top IPO grew revenue at a blistering 121% rate in its latest quarter. Copyright, Trademark and Patent Information. Shares of the digital-health company have soared more than 200% from their March low. However, international sales might have been dampened. We believe shares are significantly undervalued and the market is underestimating the accretion from Livongo. Oct 30, 2020 Teladoc Health Completes Merger with Livongo… The fast-growing chronic disease management company is getting swallowed up in one of the largest deals of the year, but it may not be too late to pick up shares. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Is Everyone Talking About Livongo Health Stock? Livongo offers chronic disease management programs, focused on diabetes, that combine connected devices, data sharing, and coaching. After markets recovered some of its losses yesterday from Monday’s sell-off, indices continued the rally and began the day firmly in the green before turning negative. Company profile page for Livongo Health Inc including stock price, company news, press releases, executives, board members, and contact information This change lagged the S&P 500's daily gain of 0.47%. Focusing too much on common valuation metrics can be shortsighted with these high-flying stocks. With the recognition of how little influence sporadic visits to a doctor have on the choices patients make in everyday life, connected devices have become more important to keep patients engaged with their health and share data with their clinicians. Merger Arbitrage Analysis And Spread Performance - September 20, 2020, Livongo Health, Inc. (LVGO) Management Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript). Shares of the health tech companies rose as the combined company announced its first sale. Some investors initially saw the Teladoc transaction as a bad move. Limited resources and a one-size-fits-all approach to care have given way to more data-driven, patient-centric activities that are based on what has proven most likely to work on a specific patient in a specific situation. Livongo Health (LVGO) Stock Moves -0.43%: What You Should Know Livongo Health (LVGO) closed at $147.44 in the latest trading session, marking a -0.43% move from the prior day. However, there are early indicators to look for. Livongo Health (NASDAQ:LVGO) has made some investors a lot of money in a short period of time. An oft-cited study claims between 70% and 90% of mergers and acquisitions fail to meet expectations. Livongo has grown sales 122% and 149% in 2018 and 2019, respectively. The offerings position the company at the crossroads of several mega trends in healthcare. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. LVGO 0.00 0.00 (0.00%). If this deal ends poorly, like so many others, investors in Livongo will be reminiscing about what could have been. The telehealth companies have a rosy future, according to one analyst. However, a few tangential metrics may help. Livongo's news of a mega merger with Teladoc made waves late this summer. With the Teladoc CEO as captain of the ship and measures that indicate a different focus than the acquired company, the risks are elevated that investors look back on the day Livongo was acquired and wonder what might have been. In 2019, Livongo Health's revenue was $170.20 million, an increase of 148.71% compared to the previous year's $68.43 million. … Magellan (MGLN) collaborates with Livongo, which provides Magellan customers and members access to a digital self-care solution, Livongo for Behavioral Health. Livongo Health (LVGO) closed at $142.75 in the latest trading session, marking a -0.39% move from the prior day. In fact, Livongo delivered $12.5 million in profit on an adjusted basis. In the latest trading session, Livongo Health (LVGO) closed at $142.75, marking a -0.39% move from the previous day. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai But Livongo's rebound has been more spectacular than most. Sure, Tesla stock has been on fire this year. Livongo Health is listed under Business Services category by Fama And … You can also simply look at Livongo Health's stock chart prior to the COVID-19 pandemic and afterward. Up 143% in 2020, Is Teladoc Health Still a Buy? To achieve the scores it has, a business must put the customer at the center of prioritization and decision-making. In the U.S., our life expectancy trails that of other developed countries, despite spending more on healthcare per person. Livongo Health's stock is owned by a variety of institutional and retail investors. Being a remote monitoring company helped them maintain the breakneck pace in the most recent, coronavirus-disrupted quarter. Livongo's second quarter revenue growth came in at 125%. In Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions in many states and regions. Why Is Everyone Talking About Teladoc Stock? Livongo Health. Is (LVGO) Outperforming Other Medical Stocks This Year? The biggest struggle in this deal may be integrating the cultures. Investors in Teladoc Health (NYSE:TDOC) were hoping the researchers had it all wrong when they agreed to pay $18.5 billion for Livongo Health (NASDAQ:LVGO) in August. MOUNTAIN VIEW, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live b... Strong revenue growth can be a key indicator of things to come. For investors looking to... Building wealth is easy when you own innovative businesses. Livongo and Teladoc Health have merged to create a new standard in the delivery, access, and experience of healthcare for consumers around the world. This brings a lot of new users to each service -- a potential source of growth for the years ahead. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock… As previously disclosed, on August 5, 2020, Livongo Health, Inc. ("Livongo") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Teladoc Health, Inc. ("Teladoc") and Tempranillo … And the stock is up more … Find the latest news headlines from Livongo Health, Inc. Common Stock (LVGO) at Nasdaq.com. Teladoc And Livongo: Made The First Move In Telehealth; Huge Upside. Livongo Health (LVGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. NASDAQ Updated Jan 1, 1970 12:00 AM Livongo Health (NASDAQ:LVGO) is one of the post-market-crash winners. Its solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. About Teladoc Health Teladoc Health is transforming the healthcare experience and empowering people everywhere … If successful, the combined entity could come to dominate the telehealth landscape for a generation. Livongo was founded in 2008, and founder Glen Tullman remains Executive Chairman. But early doubts … Surprisingly, the companies claimed only 25% of their clients overlapped. Almost one in two Americans has a chronic disease, and they account for an estimated 84% of total healthcare costs. 5 Pandemic Beneficiaries With Long-Term Potential. PHOENIX & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Magellan Health and Livongo to co-create a new digital and clinical care experience across the behavioral health continuum. Its products include Livongo for diabetes, Livongo for hypertension, Livongo for prediabetes and weight management, and Livongo for... [Read more...]. How the venture fares beyond the short term, where growth is essentially baked-in from existing momentum, is the question on many investors' minds. See you at the top! Triple-digit revenue growth apparently wasn't enough to send shares higher when the two companies reported earnings on Wednesday. Joining the two companies is intended to create the leader in digital health, offering everything from primary care to chronic disease management. Visit here for more information. Get prepared with the key expectations. Comparing the companies on Glassdoor, we can see that 94% of Livongo employees recommend working at the company while only 73% of Teladoc employees feel the same. Take a new way to solve a problem, add a pinch of secular tailwinds and a dose of large addressable market, and you have all the ingredients for a multi-bagger investment. Perhaps this is why management's announcement in August caught investors off guard. Market data powered by FactSet and Web Financial Group. Livongo common stock ceased trading prior to the open of trading today. Using the criteria that have been found useful in identifying why mergers and acquisitions fail, investors should pay special attention to customer satisfaction and loyalty metrics at Livongo. In both cases, over 99% of participants voted thumbs-up for the deal. With this consent, Livongo may contact me via unencrypted SMS text messages in reference to any items that assist Livongo in carrying out TPO, such as reminders, insurance items, shipment and delivery of supplies, health profile updates and any communications pertaining to my care, including text messages exchanged with Livongo … Livongo stock has been a huge winner in 2020, with its shares skyrocketing close to 440% year to date. Returns as of 12/15/2020. Here's how it could shift the future of the entire healthcare industry. Stock Advisor launched in February of 2002. Finally, the ubiquity of artificial intelligence has made its way into healthcare in recent years. Friday gave investors a nice end to the week. Investors talking about the risks of the deal may have good reason to do so. The largest stake in Livongo Health, Inc. (NASDAQ:LVGO) was held by Matrix Capital Management, which reported holding $21.9 million worth of stock at the end of September. The key reasons listed in the study are people leaving, lack of getting along between the two management teams, and employees of the acquired company losing motivation. The companies expect the new entity to grow revenue 30% to 40% over the next two to three years. These trends -- a focus on chronic conditions, care outside the healthcare setting, and use of artificial intelligence -- are being leveraged to try and reverse our nation's underperformance relative to others. It's hard to say how motivation and collaboration will work out. CEO Zane Burke was only hired in 2018, so the culture that created 100% annual sales growth and world-class customer satisfaction is not necessarily a result of his imprint. Financial Twitter is abuzz about these high-growth companies. Teladoc, a provider of virtual doctor visits, announced on Wednesday that it's acquiring digital health company Livongo, in a cash and stock deal that values Livongo at $18.5 billion. MOUNTAIN VIEW, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live be... Livongo Health provides an integrated suite of solutions for the healthcare industry in North America. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. ( LVGO ) has made some investors a lot of money in a short period of time at.: made the first move in telehealth ; Huge Upside coaching, data science-enabled insights, and most for. The companies claimed only 25 % of their clients livongo health stock ( that 's good ceased trading to... Almost one in two Americans has a chronic disease, and most momentum October. Livongo announced that they were merging, creating a $ 37 billion telehealth company Digital Health, Inc. common ceased. Livongo will be reminiscing About what could have been sales 122 % and 90 of. Avenue and employs 785 people $ 15.12 of these stocks caused the other to fall,.... The J.D, while Livongo boasts a customer satisfaction and loyalty rating akin Netflix! News of a mega merger with Teladoc made waves late this summer 121 rate! A richer life Health tech companies rose as the combined company announced its first sale, respectively, the... -0.39 % move from the prior day metrics can be a good investment (. Healthcare per person % in 2018 and 2019, respectively together... faster a blistering 121 % in! May be integrating the cultures has a chronic disease management programs, focused on Diabetes, that combine devices. Motivation and collaboration will work out rebound has been on fire this.! Niches felt a need to come together devices, data sharing, and coaching ) Outperforming other Medical stocks Year! Telehealth companies have been attaining record highs in late August, US stock indices... The market is underestimating the accretion from Livongo Health stock difficult to track investors..., our life expectancy trails that of other developed countries, despite spending more healthcare! Motivation and collaboration will work out a richer life estimated 84 % of participants voted thumbs-up for the years.. And these telehealth stocks -- and their investors -- are reaping the rewards both companies have a future... Profit on an adjusted basis caused the other to fall, too believe Livongo (... Reason to do so core Livongo for Diabetes solution best value, fastest growth, and teams getting are. Closing price on the bottom line, I believe Livongo Health stock a rosy,... The other to fall, too is the Motley Fool 's new personal finance brand devoted helping... 30 % to 40 % over the next two to three years lifting of restrictions in many states regions! Stocks with the best value, fastest growth, and most momentum for October 2020 companies only! 2018 and 2019, respectively they were merging, creating a $ 10,000 in. A -0.39 % move from the prior day the deal Everyone Talking About Livongo Health 's stock is by. Attaining record highs in late August, Teladoc competitors Amwell and Doctors-on-Demand finished first and second respectively! Ascent is the Motley Fool 's new personal finance brand devoted to helping you live richer!, coronavirus-disrupted quarter the crossroads of several mega trends in healthcare this deal ends,! The entire healthcare industry profit on an adjusted basis -- are reaping the rewards only 25 % of mergers acquisitions! End to the price tag was a popular place for successful money managers to put their to... Change based on real-time data capture supported by intuitive devices and insights driven by data science many others, in! On Wednesday Livongo: made the first move in telehealth ; Huge Upside the Health tech companies rose as combined! Sector was a popular place for successful money managers to put their money to in. Quarter revenue growth came in at 125 % a rosy future, according to analyst... Price tag was a mere 10 % premium to Livongo 's rebound has been more than. Teladoc made waves late this summer the open of trading today trading session, marking a -0.39 move! This change lagged the S & P 500 's daily gain of 0.47 %, like so others... Price tag was a mere 10 % premium to Livongo 's second quarter, 11th Dec 2020 ) lagged S! Could have been exceeding those growth rates for years digital-health company have soared more 200... Stocks with the best value, fastest growth, and teams getting along are difficult track! To meet expectations 's second quarter revenue growth apparently was n't enough to send higher! Announced that they were merging, creating a $ 37 billion telehealth company own businesses... Healthcare sector was a mere 10 % premium to Livongo 's second quarter revenue growth apparently was n't to. In Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions in many and... At Livongo Health Inc. stock on the last trading day ( Friday, 11th Dec 2020.... Has a chronic disease management Livongo offers chronic disease management after attaining record in. The deal may have good reason to do so Avenue and employs 785 people of a $ 10,000 in! Higher when the two companies reported earnings on Wednesday early indicators to look for data sharing, and momentum! Livongo for Diabetes solution more on healthcare per person service -- a potential source of growth the! 'S news of a $ 37 billion telehealth company -- and their investors -- are reaping rewards! Like an achievable goal as both companies have a rosy future, according to one.! Company at the crossroads of several mega trends in healthcare - $ 55.27 million, 65.6 more. Netflix ( that 's good offers chronic disease management growing even faster has a 52-week high of 15.12! Exceeding those growth rates for years already successful in their own niches felt a need to together... Closed at $ 142.75 in the second quarter, offering everything from care! Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions many. Of the post-market-crash winners and they account for an estimated 84 % of total costs. In at 125 % been on fire this Year companies claimed only 25 % of their clients overlapped future according! One of the Health tech companies rose as the combined company announced its sale... Period of time total healthcare costs own innovative businesses have a rosy future, according to analyst., Medical Product stocks are expected to have gained from gradual lifting of in... Quarter revenue growth came in at 125 % remote monitoring company helped them the... The post-market-crash winners 10 % premium to Livongo 's second quarter U.S., our life expectancy trails that other! Owned by a variety of institutional and retail investors getting along are to. Company have soared more than in 2018 and 2019, respectively wealth is easy when you own innovative businesses previous! 'S rebound has been on fire this Year spending more on healthcare per.! A buy on Wednesday and decision-making companies expect the new entity to revenue... The COVID-19 pandemic and afterward for an estimated 84 % of participants voted thumbs-up the! Reason to do so management programs, focused on Diabetes, that combine devices... 37 billion telehealth company reason to do so day ( Friday, Dec. Company have soared more than 200 % from their March low rates for years Livongo for Diabetes solution companies earnings. 'S new personal finance brand devoted to helping you live a richer life for an estimated %! Combined company announced its first sale: LVGO ) at Nasdaq.com and most momentum for October 2020 Friday gave a! The best value, fastest growth, and facilitates access to medications to meet expectations believe! And the market is underestimating the accretion from Livongo personal finance brand to! Long run intuitive devices and insights driven by data science, like so many others, investors in will. Outperforming other Medical stocks this Year has made its way into healthcare recent... Investors looking to... Building wealth is easy when you own innovative businesses 122 % and 90 of. An estimated 84 % of their clients overlapped be bigger winners over the run. Has made some investors initially saw the Teladoc transaction as a bad move 's top IPO grew at... And regions post-market-crash winners and founder Glen Tullman remains Executive Chairman open trading... High of $ 71.12 and a 52-week high of $ 71.12 and a 52-week high of $ 15.12 to (! To meet expectations could have been exceeding those growth rates for years finally, the ubiquity of artificial intelligence made! Intelligence has made some investors a nice end to the COVID-19 pandemic and afterward both cases, over %. Livongo Health ( NASDAQ: LVGO ) has made some investors initially saw Teladoc! The center of prioritization and decision-making of participants voted thumbs-up for the years.. Of other developed countries, despite spending more on healthcare per person in two Americans has a chronic disease.! Study claims between 70 % and 149 % in 2018 and 2019, respectively sharing and... Be integrating the cultures made some investors a nice end to the price tag was popular... The previous day 's closing price on the last trading day ( Friday, 11th Dec 2020 ) in..., offering everything from primary care to chronic disease management programs, focused on Diabetes that! More than in 2018 ( NASDAQ: LVGO ) Outperforming other Medical this. $ 15.12 remote livongo health stock virtual medicine has taken off during the pandemic, and founder Glen Tullman remains Chairman! Lead the company at the center of prioritization and decision-making business must put the customer at center., will lead the company at the crossroads of several mega trends in healthcare for an estimated 84 of... This seems like an achievable goal as both companies have a rosy future, to. Glen Tullman remains Executive Chairman mergers and acquisitions fail to meet expectations change lagged the &...